[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bayer Ag ADR (BAYRY)

Bayer Ag ADR (BAYRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 53,448,000
  • Shares Outstanding, K 3,930,000
  • Annual Sales, $ 51,564 M
  • Annual Income, $ -4,096 M
  • EBIT $ 462 M
  • EBITDA $ 3,613 M
  • 60-Month Beta 0.55
  • Price/Sales 1.02
  • Price/Cash Flow 6.15
  • Price/Book 1.56
  • Price/Earnings ttm 9.01
  • Earnings Per Share ttm 1.49
  • Most Recent Earnings $0.79 on 05/12/26
  • Next Earnings Date 08/05/26 [--]
  • Annual Dividend & Yield (Fwd) 0.02 (0.18%)
  • Most Recent Dividend 0.024 on 04/28/26
  • Sector Medical
  • INDUSTRY GROUPING Large Cap Pharma

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.23
  • Number of Estimates 2
  • High Estimate $0.25
  • Low Estimate $0.20
  • Prior Year $0.35
  • Growth Rate Est. (year over year) -34.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.9100 +22.27%
on 06/23/26
15.2300 -12.41%
on 07/02/26
+2.5300 (+23.40%)
since 06/22/26
3-Month
9.5840 +39.19%
on 06/02/26
15.2300 -12.41%
on 07/02/26
+1.6000 (+13.63%)
since 04/22/26
52-Week
7.1900 +85.54%
on 08/06/25
15.2300 -12.41%
on 07/02/26
+5.1900 (+63.68%)
since 07/22/25

Most Recent Stories

More News
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months Autonomy technology is designed to lower capital expenditures and...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials

Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart

One A Day®, the multivitamin and supplement brand from Bayer, has partnered with country superstar and five time Entertainer of the Year Luke Bryan to launch a limited edition multivitamin bottle featuring...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon

Advances key component of Crop Science division’s Five-Year Framework strategy Reinforces commitment to delivering trusted Roundup ® brands and glyphosate...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Bayer and Iambic Collaborate to Advance Drug Discovery with AI

Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada

The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees working...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Bayer Completes Acquisition of Perfuse Therapeutics

Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously ,...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief

Key Facts Campaign: Project DIY is a new campaign under Aleve’s recently launched Feel Aleve ® platform. Project DIY showcases how, when...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions

Key Facts: Bayer’s AMBELVIST ® (gadoquatrane) becomes the lowest-dose macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) approved...

BAYRY : 13.3400 (-1.91%)
BAYZF : 54.9600 (-1.86%)
BAYN : 0.0100 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses....

See More

Key Turning Points

3rd Resistance Point 13.5167
2nd Resistance Point 13.4733
1st Resistance Point 13.4067
Last Price 13.3400
1st Support Level 13.2967
2nd Support Level 13.2533
3rd Support Level 13.1867

See More

52-Week High 15.2300
Last Price 13.3400
Fibonacci 61.8% 12.1587
Fibonacci 50% 11.2100
Fibonacci 38.2% 10.2613
52-Week Low 7.1900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.